Observational Real-world Evaluation of Cost of Infections of RA Patients on Biologics.
Phase of Trial: Phase IV
Latest Information Update: 12 Apr 2012
At a glance
- Drugs Abatacept; Adalimumab; Etanercept; Infliximab
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 12 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Dec 2011 Planned End Date changed from 1 Dec 2011 to 1 Mar 2012 as reported by ClinicalTrials.gov.
- 29 Aug 2011 Planned end date changed from Dec 2010 to Dec 2011 as reported by ClinicalTrials.gov.